Martingale Asset Management L P Dyne Therapeutics, Inc. Transaction History

Martingale Asset Management L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$10.88 - $15.0 $270,096 - $372,375	-24,825 Reduced 70.39%	10,441 $120,000
Q4 2022 Feb 13, 2023	BUY	$9.37 - $13.8 $330,442 - $486,670	35,266 New	35,266 $408,000
Q1 2022 May 12, 2022	SELL	$6.52 - $12.27 $207,427 - $390,357	-31,814 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$11.89 - $16.07 $378,268 - $511,250	31,814 New	31,814 $378,000

210

102M

234K

238K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.54B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.